New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
